INDUSTRY / PUBLIC SOURCE RECORD
Health and life science
- The page presents Norway as a partner in sustainable health and research, with strengths in radiopharma, biopharma, medical technology and digital health. Its About page says the country combines public universal healthcare, high per-capita health spending, government-supported research infrastructure, collaboration among universities/hospitals/research/public authorities/investors/companies, decades of systematically collected health data and accessible registries, and a highly digitalized society and healthcare sector.
- Listed technical areas include AI, ultrasound, immuno-oncology, antibodies, cell and gene therapy, nanotechnology, radiopharmaceuticals, and in-vivo and in-vitro diagnostics. It also cites clean energy and water, advanced technology and recycling as advantages for sustainable manufacture of medical products and components. The page highlights Kavli Institute for Systems Neuroscience, led by Nobel laureates Edvard and May-Britt Moser.
- The About page’s additional business points are strict health-product regulation; a skilled, autonomous workforce and trust-based industrial culture; near-universal internet/mobile coverage and strong digital skills; strong R&D clusters and international partnerships; EEA single-market integration; political/economic stability; and high quality of life, public safety, work-life balance, healthcare, higher education, gender equality, family leave and childcare.
- Overview features four solutions: Bulbitech eye-movement and AI diagnostics for eye and neurological diseases; Arctic Bioscience’s high-DHA phospholipid extract from sustainable herring roe; RoomMate’s safety sensor for detecting/reducing falls; and Marealis marine peptides from prawn shells for blood-pressure health. Linked articles cover Norway’s role in alpha therapy/radiopharmaceuticals, software for health-research collaboration, and Norwegian digital healthcare in the UK. A radiopharma feature links to the separate sitemap page at
/industries/health-and-life-science/radiopharma. - The page lists 5 of 48 companies: Bulbitech AS (eye/neurological disease diagnostics and management using eye-movement data and AI); Biosan AS (Norwegian supplements using documented ingredients, with nearly 40 years’ experience); Oxyo AS (pressure tanks and hyperbaric oxygen therapy chambers, including rentals); Aidn AS (tools for health professionals, patients and families addressing ageing and workforce shortages); and Norlense AS (oil-spill recovery solutions and inflatable preparedness tents, established in 1975).
- Events tab lists 3: “Meet Norway’s oncology clinicians at ESMO 2026” (23–27 October 2026); “Come and meet Team Norway at Science Conference” (Singapore, 5 November 2026, 08:30–20:00); and “Meet Team Norway at HLTH Vegas 2026” (Las Vegas, 15–18 November 2026). Overview also features “Meet Team Norway at NLS Days 2026” in Sweden (8–9 September 2026) and the HLTH Vegas event.
- Team Norway for the health and life-science export initiative comprises the Ministry of Foreign Affairs (missions lead Team Norway and political dialogue), Innovation Norway (official trade/investment promotion and strategic/operational leadership), and Export Finance Norway (Eksfin; export-credit loans and guarantees with commercial banks). The page lists supporting clusters: Electronic Coast, Norway Health Tech, Norwegian Smart Care Cluster, Oslo Cancer Cluster and The Life Science Cluster. The overview also names the Research Council of Norway and Siva among the official Team Norway actors for the sector.
- Public advisor contacts shown (role; email; phone; LinkedIn when listed): Tone Varslot Stave, Head of national export initiative on health and life science, Innovation Norway; tone.varslot.stave@innovasjonnorge.no; +47 952 25 533. Ingeborg Frøysnes, Special Advisor, Scaleups and AI, Brussels; Ingeborg.Froysnes@innovationnorway.no; +47 480 67 792. Janne T. Morstøl, Director, Innovation Norway France; janne.t.morstol@innovationnorway.no; +47 951 96 224; linkedin.com/in/janne-t-morst%C3%B8l-7127bb3/. John Vislosky, Senior Advisor, Health Tech, New York; john.vislosky@innovationnorway.no; +1 917 855 8866; linkedin.com/in/john-vislosky-mba-08043322/. Maren Jervell Lund, Senior Advisor & TEA Programme, UK and Ireland; maren.jervell.lund@innovationnorway.no; +44 (0) 7741892217; linkedin.com/in/maren-jervell-lund/. Martin Nietz, Senior Advisor, D-A-CH, Munich; martin.nietz@innovationnorway.no; +49 171 4260170. Urmas Lepik, Senior International Business Advisor, Copenhagen, Denmark; urmas.lepik@innovationnorway.no; +45 20 91 43 97; linkedin.com/in/urmas-lepik-8529b810/. Erle Hauso, Senior Advisor, Health and life science; erle.hauso@innovasjonnorge.no; +47 971 28 283; linkedin.com/in/erle-hauso-5105742/.
- No fees or participation prices were displayed on this industry page.